Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 52 | 33 | 0 | 0 | 0 |
| Gross Profit | 52 | 33 | N/A | N/A | N/A |
| Operating Expenses | 6,668 | 6,089 | 2,017 | 640 | -14,900 |
| Operating Income | -6,616 | -6,056 | -2,017 | -640 | 9,881 |
| Interest Expense | 180 | 13 | 0 | 0 | -916 |
| Other Income | 190 | 4 | -70 | -91 | 444 |
| Pre-tax Income | -6,606 | -6,065 | -2,087 | -731 | 11,241 |
| Net Income Continuous | -6,606 | -6,065 | -2,087 | -731 | 11,241 |
| Net Income Discontinuous | -688 | -1,337 | N/A | N/A | N/A |
| Net Income | $-7,294 | $-7,402 | $-2,087 | $-731 | $11,241 |
| EPS Basic Total Ops | 2.31 | -0.77 | -3.24 | -1.15 | 2.37 |
| EPS Basic Continuous Ops | 2.50 | -0.63 | -3.24 | -1.15 | 2.39 |
| EPS Basic Discontinuous Ops | -0.19 | -0.14 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 2.31 | -0.77 | -3.24 | -1.15 | 2.37 |
| EPS Diluted Continuous Ops | 2.50 | -0.63 | -3.24 | -1.15 | 2.39 |
| EPS Diluted Discontinuous Ops | -0.19 | -0.14 | N/A | N/A | N/A |
| EBITDA(a) | $-6,479 | $-5,874 | $-2,015 | $-637 | $14,904 |